Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3365 | Thyroidectomy Wiki | 0.71 |
| drug3538 | Venous blood was collected for biochemistry testing. Wiki | 0.71 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D013959 | Thyroid Diseases NIH | 1.00 |
| D007249 | Inflammation NIH | 0.13 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There are 2 clinical trials
Italy has been on the frontline of the COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, the need to focus resources to deal with the pandemic led to a disruption of routine surgical care, as well as activity for oncologic and chronic disease. The aim of this study was to evaluate the impact of COVID-19 pandemic on surgical activity of the Italian Units of Endocrine Surgery belonging to the SIUEC (Italian Society of Endocrine Surgery), the most important national scientific society of endocrine surgery.The aim of this study was to evaluate the impact of COVID-19 pandemic on surgical activity of the Italian Units of Endocrine Surgery belonging to the SIUEC (Italian Society of Endocrine Surgery), the most important national scientific society of endocrine surgery.
Description: Comparison between the number of patients operated during COVID-19 pandemic with aggressive thyroid carcinoma (with lymph node metastasis, and/or extrathyroidal extension, and/or multifocality) with patients with aggressive thyroid carcinoma operated during the same period of the previous year
Measure: Quantify the number of aggressive tumors operated during COVID-19 pandemic and the same period of the previous year Time: 1 yearCOVID-19 infection causes a hypersensitive immune reaction and widespread inflammation through cytokines in various organs of the body, especially the lungs. This cytokine-mediated widespread inflammation can also affect the thyroid gland, causing thyroiditis and impaired thyroid functions. The researchers evaluated thyroid function tests and thyroid autoantibodies in patients hospitalized for COVID-19 infection. Researchers excluded patients on intensive care therapy and patients with known thyroid disease. The researchers examined the relationship of thyroid hormones and thyroid autoantibodies to COVID-19 disease, white blood cells, neutrophil / lymphocyte ratio, c reactive protein, fibrinogen, procalcitonin, ferritin, and D-dimer stages in these patients. Researchers compared changes in thyroid hormones and autoantibodies in people without COVID-19 infection and without thyroid disease.
Description: In the study, serum TSH results of the Covid patient group and non-Covid control groups were recorded and compared statistically.
Measure: Comparison of thyroid stimulating hormone (TSH) between groups Time: 90 daysDescription: In the study, serum fT3 results of the Covid patient group and non-Covid control groups were recorded and compared statistically.
Measure: Comparison of free triiodothyronine (fT3) between groups Time: 90 daysDescription: In the study, serum fT4 results of the Covid patient group and non-Covid control groups were recorded and compared statistically.
Measure: Comparison of free thyroxine (fT4) between groups Time: 90 daysDescription: In the study, serum anti-TPO results of the Covid patient group and non-Covid control groups were recorded and compared statistically.
Measure: Comparison of anti-thyroid peroxidase (Anti-TPO) between groups Time: 90 daysDescription: In the study, serum anti-Tg results of the Covid patient group and non-Covid control groups were recorded and compared statistically.
Measure: Comparison of anti-thyroglobulin (Anti-Tg) between groups Time: 90 daysDescription: In the study, serum WBC results were recorded in Covid 19 patient groups.
Measure: White blood cells (WBC) results of Covid 19 patient group Time: 90 daysDescription: In the study, serum N/LO results were recorded in Covid 19 patient groups.
Measure: Neutrophil / lymphocyte ratio (N/LO) results of Covid 19 patient group Time: 90 daysDescription: In the study, serum CRP results were recorded in Covid 19 patient groups.
Measure: C-reactive protein (CRP) results of Covid 19 patient group Time: 90 daysDescription: In the study, serum fibrinogen results were recorded in Covid 19 patient groups.
Measure: Fibrinogen results of Covid 19 patient group Time: 90 daysDescription: In the study, serum procalcitonin results were recorded in Covid 19 patient groups.
Measure: Procalcitonin results of Covid 19 patient group Time: 90 daysDescription: In the study, serum ferritin results were recorded in Covid 19 patient groups.
Measure: Ferritin results of Covid 19 patient group Time: 90 daysDescription: In the study, serum D-dimer results were recorded in Covid 19 patient groups.
Measure: D-dimer results of Covid 19 patient group Time: 90 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports